Bavarian Nordic (OTCMKTS:BVNRY) Stock Passes Below 50 Day Moving Average – Here’s What Happened

Shares of Bavarian Nordic (OTCMKTS:BVNRY) crossed below its fifty day moving average during trading on Monday . The stock has a fifty day moving average of $10.06 and traded as low as $10.03. Bavarian Nordic shares last traded at $10.03, with a volume of 248 shares trading hands.

Bavarian Nordic Stock Up 1.0%

The stock has a market capitalization of $2.38 billion, a P/E ratio of 6.47 and a beta of 1.37. The business’s 50 day simple moving average is $10.06 and its two-hundred day simple moving average is $10.93.

Bavarian Nordic (OTCMKTS:BVNRY) last posted its earnings results on Friday, November 14th. The company reported $0.72 earnings per share for the quarter. Bavarian Nordic had a net margin of 35.96% and a return on equity of 20.47%. The company had revenue of $281.11 million for the quarter. Analysts predict that Bavarian Nordic will post 0.67 earnings per share for the current year.

Bavarian Nordic Company Profile

Bavarian Nordic is a fully integrated biotechnology company specializing in the development, manufacture and commercialization of vaccines and immunotherapies. Founded in 1994 and headquartered in Martinsried, Germany, the company combines internal research capabilities with in-house manufacturing to address serious infectious diseases and cancer indications. Bavarian Nordic’s operations encompass preclinical research, clinical development and commercial supply, with a strategic focus on leveraging its proprietary viral vector platforms.

The company’s commercial portfolio includes approved prophylactic vaccines such as Jynneos™ (marketed as Imvamune®/Imvanex®) for the prevention of smallpox and monkeypox in the United States, European Union and Canada; Rabipur® for rabies prevention; and Encepur® against tick-borne encephalitis.